NCT02631031View on ClinicalTrials.gov

Chronopharmacology of Valsartan in Normotensive Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

January 31, 2017

Conditions
Healthy Normotensive Volunteers
Interventions
DRUG

Valsartan

single oral dose of 160 mg valsartan under fasting conditions

Trial Locations (1)

11566

Ain Shams university, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT02631031 - Chronopharmacology of Valsartan in Normotensive Subjects | Biotech Hunter | Biotech Hunter